会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明公开
    • BETA-HAIRPIN PEPTIDOMIMETICS HAVING CXCR4 ANTAGONIZING ACTIVITY
    • BET EL EL EL KA KA MCR CXCR4-ANTAGONISIERENDER WIRKUNG
    • EP2427476A1
    • 2012-03-14
    • EP09779424.2
    • 2009-05-07
    • Polyphor Ag
    • OBRECHT, DanielGOMBERT, Frank, OttoLEDERER, AlexanderROMAGNOLI, BarbaraBISANG, Christian
    • C07K7/08C07K7/02A61K38/10A61P29/00A61P31/18A61P35/00
    • C07K7/08C07K1/061C07K7/02
    • &bgr;-Hairpin peptidomimetics of the general formula Cyclo(-Xaa1-Xaa2-Xaa3-Cys4-Xaa5-Xaa6-Xaa7-Xaa8-Arg9-Tyr10-Cys11-Xaa12-Xaa13-Xaa14-Xaa15-Xaa16-), disulfide bond between Cys4 and Cys11, and pharmaceutically acceptable salts thereof, with Xaa1, Xaa2, Xaa3, Xaa5, Xaa6, Xaa7, Xaa8, Xaa12, Xaa13, Xaa14, Xaa15 and Xaa16 being amino acid residues of certain types which are defined in the description and the claims, have CXCR4 antagonizing properties and can be used for preventing HIV infections in healthy individuals or for slowing and halting viral progression in infected patients; or where cancer is mediated or resulting from CXCR4 receptor activity; or where immunological diseases are mediated or resulting from CXCR4 receptor activity; or for treating immunosuppression; or during apheresis collections of peripheral blood stem cells and/or as agents to induce mobilization of stem cells to regulate tissue repair. These peptides can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
    • 通式为(Xaa1-Xaa2-Xaa3-Cys4-Xaa5-Xaa6-Xaa7-Xaa8-Arg9-Tyr10-Cys11-Xaa12-Xaa13-Xaa14-Xaa15-Xaa16-)的通式肽模拟物,Cys4之间的二硫键 和Cys11及其药学上可接受的盐与在说明书和权利要求书中定义的某些类型的氨基酸残基的Xaa1,Xaa2,Xaa3,Xaa5,Xaa6,Xaa7,Xaa8,Xaa12,Xaa13,Xaa14,Xaa15和Xaa16, 具有CXCR4拮抗特性,可用于预防健康个体的艾滋病毒感染或减缓和阻止感染患者的病毒进展; 或由CXCR4受体活性介导或产生癌症; 或其中免疫性疾病介导或由CXCR4受体活性产生; 或用于治疗免疫抑制; 或在外周血干细胞的分离采集期间和/或作为诱导干细胞调动以调节组织修复的试剂。 这些肽可以通过基于混合固相和溶液相合成策略的方法制造。
    • 47. 发明公开
    • BETA-HAIRPIN PEPTIDOMIMETICS
    • BETA-HAIRPIN多肽
    • EP3201218A1
    • 2017-08-09
    • EP15778875.3
    • 2015-09-29
    • Polyphor AG
    • OBRECHT, DanielLUTHER, AnatolBERNARDINI, FrancescaDENIAU, GildasLEDERER, Alexander
    • C07K7/64
    • C07K7/64A61K38/00Y02A50/473
    • Beta-hairpin peptidomimetics of the general formula (I), cyclo[P1-P2-P3-P4-P5-P6-P7-P8-P9-P10-P11-P12-T1-T2], and pharmaceutically acceptable salts thereof, with P1 to P12, T1 and T2 being elements as defined in the description and the claims, have Gram-negative antimicrobial activity to e.g. inhibit the growth or to kill microorganisms such as Klebsiella pneumoniae and/or Acinetobacter baumannii and/or Escherichia coli. They can be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
    • 通式(I)的β-发夹肽模拟物,环[P1-P2-P3-P4-P5-P6-P7-P8-P9-P10-P11-P12-T1-T2]及其药学上可接受的盐与 P1至P12,T1和T2是说明书和权利要求书中定义的元素,对例如,具有Gramegative抗微生物活性 抑制生长或杀死微生物如肺炎克雷伯氏菌和/或鲍曼不动杆菌和/或大肠杆菌。 它们可以用作治疗或预防感染的药物,或用作食品,化妆品,药​​物或其他含营养物质的消毒剂。 这些肽模拟物可以通过基于混合固相和液相合成策略的方法制造。